Description
MVN38807, also known as Y-1, is neuraminidase (NA) inhibitor used in preparation of drugs for resisting H1N1 influenza virus. Y-1 exerts the best inhibition activity (IC50 = 0.21 μM) against NA, which is better than oseltamivir carboxylate (OSC) (IC50 = 3.04 μM) and lead AN-329/10738021 (IC50 = 1.92 μM).
Product information
CAS Number: 2379438-80-7
Molecular Weight: 317.25
Formula: C14H11N3O6
Synonym:
Y-1
MVN-38807
Y1
Y 1
MVN38807
MVN 38807
Chemical Name: Benzoic acid, 3,5-dihydroxy-, (2E)-2-[(4-hydroxy-3-nitrophenyl)methylene]hydrazide
Smiles: [O-][N+](=O)C1=CC(/C=N/NC(=O)C2C=C(O)C=C(O)C=2)=CC=C1O
InChiKey: MCGROFKAAXXTBN-VIZOYTHASA-N
InChi: InChI=1S/C14H11N3O6/c18-10-4-9(5-11(19)6-10)14(21)16-15-7-8-1-2-13(20)12(3-8)17(22)23/h1-7,18-20H,(H,16,21)/b15-7+
Technical Data
Appearance: Solid Power.
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: Soluble in DMSO
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined.
HS Tariff Code: 382200
How to use
In Vitro:
Neuraminidase-IN-1 has excellent activity against H1N1 influenza virus, has completely different structure from previous neuraminidase, has good inhibitory effect on the A/WSN/33H1N1 virus strains, and has low toxicity and good druggability.
References:
- Yu R, Cheng LP, Li M, Pang W. Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay. ACS Med Chem Lett. 2019 Nov 25;10(12):1667-1673. doi: 10.1021/acsmedchemlett.9b00447. PMID: 31857844; PMCID: PMC6912870.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.